Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in

Anne G Raafs1, Jacqueline L Vos2, Michiel T H M Henkens3

  • 1Department of Cardiology, Cardiovascular Research Institute (CARIM), Maastricht University Medical Center, Maastricht, the Netherlands.

Insights

Left atrial conduit strain measured by cardiac magnetic resonance (CMR) is a powerful predictor of adverse outcomes in dilated cardiomyopathy (DCM). This finding improves risk stratification for patients with DCM.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomarkers

Background:

  • The left atrium (LA) is a sensitive indicator of left ventricular (LV) dysfunction.
  • The prognostic significance of LA function, specifically strain, assessed via cardiac magnetic resonance (CMR) in patients with dilated cardiomyopathy (DCM) is not well-established.

Purpose of the Study:

  • To investigate the prognostic value of CMR-derived LA strain in patients diagnosed with DCM.
  • To determine if LA strain can predict adverse cardiovascular events in DCM.

Main Methods:

  • A cohort of 488 DCM patients with available CMR imaging was analyzed.
  • The primary endpoint included sudden cardiac death, heart failure hospitalization, or life-threatening arrhythmias.
  • Cubic spline analysis was used for continuous variable dichotomization.

Main Results:

  • LA conduit strain, NYHA functional class >II, and late gadolinium enhancement (LGE) were independent predictors of the primary endpoint in multivariable analysis.
  • LA conduit strain demonstrated a stronger association with outcomes than LA reservoir strain.
  • Incorporating LA conduit strain into prediction models significantly enhanced their accuracy and reclassification capabilities.

Conclusions:

  • CMR-derived LA conduit strain is a robust, independent prognostic marker in DCM.
  • LA conduit strain offers superior prognostic information compared to LV GLS, LVEF, and LAVI.
  • Integrating LA conduit strain into clinical practice can improve risk stratification for DCM patients.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
61
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
39
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
34
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
69
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
67